Global Nilotinib Market Growth 2022-2028
- LP 4871325
- 70 Pages
- February 2022
- Pharmaceuticals
The United States Nilotinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nilotinib market, reaching US$ million by the year 2028. As for the Europe Nilotinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nilotinib players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nilotinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50mg
200mg
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drugs Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nilotinib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nilotinib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nilotinib by Country/Region, 2017, 2022 & 2028
2.2 Nilotinib Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 Other
2.3 Nilotinib Sales by Type
2.3.1 Global Nilotinib Sales Market Share by Type (2017-2022)
2.3.2 Global Nilotinib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nilotinib Sale Price by Type (2017-2022)
2.4 Nilotinib Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Nilotinib Sales by Application
2.5.1 Global Nilotinib Sale Market Share by Application (2017-2022)
2.5.2 Global Nilotinib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nilotinib Sale Price by Application (2017-2022)
3 Global Nilotinib by Company
3.1 Global Nilotinib Breakdown Data by Company
3.1.1 Global Nilotinib Annual Sales by Company (2020-2022)
3.1.2 Global Nilotinib Sales Market Share by Company (2020-2022)
3.2 Global Nilotinib Annual Revenue by Company (2020-2022)
3.2.1 Global Nilotinib Revenue by Company (2020-2022)
3.2.2 Global Nilotinib Revenue Market Share by Company (2020-2022)
3.3 Global Nilotinib Sale Price by Company
3.4 Key Manufacturers Nilotinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nilotinib Product Location Distribution
3.4.2 Players Nilotinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nilotinib by Geographic Region
4.1 World Historic Nilotinib Market Size by Geographic Region (2017-2022)
4.1.1 Global Nilotinib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nilotinib Annual Revenue by Geographic Region
4.2 World Historic Nilotinib Market Size by Country/Region (2017-2022)
4.2.1 Global Nilotinib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nilotinib Annual Revenue by Country/Region
4.3 Americas Nilotinib Sales Growth
4.4 APAC Nilotinib Sales Growth
4.5 Europe Nilotinib Sales Growth
4.6 Middle East & Africa Nilotinib Sales Growth
5 Americas
5.1 Americas Nilotinib Sales by Country
5.1.1 Americas Nilotinib Sales by Country (2017-2022)
5.1.2 Americas Nilotinib Revenue by Country (2017-2022)
5.2 Americas Nilotinib Sales by Type
5.3 Americas Nilotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nilotinib Sales by Region
6.1.1 APAC Nilotinib Sales by Region (2017-2022)
6.1.2 APAC Nilotinib Revenue by Region (2017-2022)
6.2 APAC Nilotinib Sales by Type
6.3 APAC Nilotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nilotinib by Country
7.1.1 Europe Nilotinib Sales by Country (2017-2022)
7.1.2 Europe Nilotinib Revenue by Country (2017-2022)
7.2 Europe Nilotinib Sales by Type
7.3 Europe Nilotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nilotinib by Country
8.1.1 Middle East & Africa Nilotinib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nilotinib Revenue by Country (2017-2022)
8.2 Middle East & Africa Nilotinib Sales by Type
8.3 Middle East & Africa Nilotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nilotinib
10.3 Manufacturing Process Analysis of Nilotinib
10.4 Industry Chain Structure of Nilotinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nilotinib Distributors
11.3 Nilotinib Customer
12 World Forecast Review for Nilotinib by Geographic Region
12.1 Global Nilotinib Market Size Forecast by Region
12.1.1 Global Nilotinib Forecast by Region (2023-2028)
12.1.2 Global Nilotinib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nilotinib Forecast by Type
12.7 Global Nilotinib Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Nilotinib Product Offered
13.1.3 Novartis Nilotinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Nilotinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nilotinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of Other
Table 6. Global Nilotinib Sales by Type (2017-2022) & (MT)
Table 7. Global Nilotinib Sales Market Share by Type (2017-2022)
Table 8. Global Nilotinib Revenue by Type (2017-2022) & ($ million)
Table 9. Global Nilotinib Revenue Market Share by Type (2017-2022)
Table 10. Global Nilotinib Sale Price by Type (2017-2022) & (USD/Kg)
Table 11. Global Nilotinib Sales by Application (2017-2022) & (MT)
Table 12. Global Nilotinib Sales Market Share by Application (2017-2022)
Table 13. Global Nilotinib Revenue by Application (2017-2022)
Table 14. Global Nilotinib Revenue Market Share by Application (2017-2022)
Table 15. Global Nilotinib Sale Price by Application (2017-2022) & (USD/Kg)
Table 16. Global Nilotinib Sales by Company (2020-2022) & (MT)
Table 17. Global Nilotinib Sales Market Share by Company (2020-2022)
Table 18. Global Nilotinib Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Nilotinib Revenue Market Share by Company (2020-2022)
Table 20. Global Nilotinib Sale Price by Company (2020-2022) & (USD/Kg)
Table 21. Key Manufacturers Nilotinib Producing Area Distribution and Sales Area
Table 22. Players Nilotinib Products Offered
Table 23. Nilotinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nilotinib Sales by Geographic Region (2017-2022) & (MT)
Table 27. Global Nilotinib Sales Market Share Geographic Region (2017-2022)
Table 28. Global Nilotinib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Nilotinib Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Nilotinib Sales by Country/Region (2017-2022) & (MT)
Table 31. Global Nilotinib Sales Market Share by Country/Region (2017-2022)
Table 32. Global Nilotinib Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Nilotinib Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Nilotinib Sales by Country (2017-2022) & (MT)
Table 35. Americas Nilotinib Sales Market Share by Country (2017-2022)
Table 36. Americas Nilotinib Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Nilotinib Revenue Market Share by Country (2017-2022)
Table 38. Americas Nilotinib Sales by Type (2017-2022) & (MT)
Table 39. Americas Nilotinib Sales Market Share by Type (2017-2022)
Table 40. Americas Nilotinib Sales by Application (2017-2022) & (MT)
Table 41. Americas Nilotinib Sales Market Share by Application (2017-2022)
Table 42. APAC Nilotinib Sales by Region (2017-2022) & (MT)
Table 43. APAC Nilotinib Sales Market Share by Region (2017-2022)
Table 44. APAC Nilotinib Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Nilotinib Revenue Market Share by Region (2017-2022)
Table 46. APAC Nilotinib Sales by Type (2017-2022) & (MT)
Table 47. APAC Nilotinib Sales Market Share by Type (2017-2022)
Table 48. APAC Nilotinib Sales by Application (2017-2022) & (MT)
Table 49. APAC Nilotinib Sales Market Share by Application (2017-2022)
Table 50. Europe Nilotinib Sales by Country (2017-2022) & (MT)
Table 51. Europe Nilotinib Sales Market Share by Country (2017-2022)
Table 52. Europe Nilotinib Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Nilotinib Revenue Market Share by Country (2017-2022)
Table 54. Europe Nilotinib Sales by Type (2017-2022) & (MT)
Table 55. Europe Nilotinib Sales Market Share by Type (2017-2022)
Table 56. Europe Nilotinib Sales by Application (2017-2022) & (MT)
Table 57. Europe Nilotinib Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Nilotinib Sales by Country (2017-2022) & (MT)
Table 59. Middle East & Africa Nilotinib Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Nilotinib Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Nilotinib Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Nilotinib Sales by Type (2017-2022) & (MT)
Table 63. Middle East & Africa Nilotinib Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Nilotinib Sales by Application (2017-2022) & (MT)
Table 65. Middle East & Africa Nilotinib Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Nilotinib
Table 67. Key Market Challenges & Risks of Nilotinib
Table 68. Key Industry Trends of Nilotinib
Table 69. Nilotinib Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Nilotinib Distributors List
Table 72. Nilotinib Customer List
Table 73. Global Nilotinib Sales Forecast by Region (2023-2028) & (MT)
Table 74. Global Nilotinib Sales Market Forecast by Region
Table 75. Global Nilotinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Nilotinib Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Nilotinib Sales Forecast by Country (2023-2028) & (MT)
Table 78. Americas Nilotinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Nilotinib Sales Forecast by Region (2023-2028) & (MT)
Table 80. APAC Nilotinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Nilotinib Sales Forecast by Country (2023-2028) & (MT)
Table 82. Europe Nilotinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Nilotinib Sales Forecast by Country (2023-2028) & (MT)
Table 84. Middle East & Africa Nilotinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Nilotinib Sales Forecast by Type (2023-2028) & (MT)
Table 86. Global Nilotinib Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Nilotinib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Nilotinib Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Nilotinib Sales Forecast by Application (2023-2028) & (MT)
Table 90. Global Nilotinib Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Nilotinib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Nilotinib Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis Basic Information, Nilotinib Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Nilotinib Product Offered
Table 95. Novartis Nilotinib Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
List of Figures
Figure 1. Picture of Nilotinib
Figure 2. Nilotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nilotinib Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Nilotinib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nilotinib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 200mg
Figure 11. Product Picture of Other
Figure 12. Global Nilotinib Sales Market Share by Type in 2021
Figure 13. Global Nilotinib Revenue Market Share by Type (2017-2022)
Figure 14. Nilotinib Consumed in Hospital
Figure 15. Global Nilotinib Market: Hospital (2017-2022) & (MT)
Figure 16. Nilotinib Consumed in Drugs Store
Figure 17. Global Nilotinib Market: Drugs Store (2017-2022) & (MT)
Figure 18. Nilotinib Consumed in Other
Figure 19. Global Nilotinib Market: Other (2017-2022) & (MT)
Figure 20. Global Nilotinib Sales Market Share by Application (2017-2022)
Figure 21. Global Nilotinib Revenue Market Share by Application in 2021
Figure 22. Nilotinib Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Nilotinib Revenue Market Share by Company in 2021
Figure 24. Global Nilotinib Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Nilotinib Revenue Market Share by Geographic Region in 2021
Figure 26. Global Nilotinib Sales Market Share by Region (2017-2022)
Figure 27. Global Nilotinib Revenue Market Share by Country/Region in 2021
Figure 28. Americas Nilotinib Sales 2017-2022 (MT)
Figure 29. Americas Nilotinib Revenue 2017-2022 ($ Millions)
Figure 30. APAC Nilotinib Sales 2017-2022 (MT)
Figure 31. APAC Nilotinib Revenue 2017-2022 ($ Millions)
Figure 32. Europe Nilotinib Sales 2017-2022 (MT)
Figure 33. Europe Nilotinib Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Nilotinib Sales 2017-2022 (MT)
Figure 35. Middle East & Africa Nilotinib Revenue 2017-2022 ($ Millions)
Figure 36. Americas Nilotinib Sales Market Share by Country in 2021
Figure 37. Americas Nilotinib Revenue Market Share by Country in 2021
Figure 38. United States Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Nilotinib Sales Market Share by Region in 2021
Figure 43. APAC Nilotinib Revenue Market Share by Regions in 2021
Figure 44. China Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Nilotinib Sales Market Share by Country in 2021
Figure 51. Europe Nilotinib Revenue Market Share by Country in 2021
Figure 52. Germany Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Nilotinib Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Nilotinib Revenue Market Share by Country in 2021
Figure 59. Egypt Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Nilotinib Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Nilotinib in 2021
Figure 65. Manufacturing Process Analysis of Nilotinib
Figure 66. Industry Chain Structure of Nilotinib
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
